Clinical Trials Browser

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT00520975 2025-03-28

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Phase 3 Terminated

96 enrolled 16 charts

Breast

Breast Neoplasms

NCT03936933 2025-02-17

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

Phase 3 Terminated

6 enrolled

Breast

Breast Neoplasms

NCT03498716 2024-08-21

IMpassion030

Phase 3 Terminated

2,199 enrolled 13 charts

Breast

Triple Negative Breast Neoplasms

NCT04395339 2024-08-01

GLORY

Phase 3 Terminated

51 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Gangliosidoses, Radiation Injuries, Gangliosidosis, GM1, Cognitive Dysfunction

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Phase 3 Terminated

76 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT05207514 2024-05-17

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Phase 3 Terminated

26 enrolled

Breast

Breast Neoplasms

NCT05134194 2024-04-16

A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer

Phase 3 Terminated

1 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05065411 2024-02-26

VERU-024

Phase 3 Terminated

5 enrolled

Breast

Breast Neoplasms

NCT04869943 2024-01-26

ARTEST

Phase 3 Terminated

52 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT03786094 2023-11-01

FORTRESS

Phase 3 Terminated

432 enrolled 13 charts

Breast

Breast Neoplasms

NCT01303679 2023-09-06

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Phase 3 Terminated

117 enrolled

Breast

First Line Metastatic Breast Cancer

NCT04385433 2023-08-24

PRAVAPREV-01

Phase 3 Terminated

15 enrolled

Breast

Breast Neoplasms

NCT03152929 2023-06-06

Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)

Phase 3 Terminated

89 enrolled 14 charts

Breast

Agnosia, Breast Neoplasms

NCT04335006 2023-05-06

A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

Phase 3 Terminated

80 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00272987 2023-04-28

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Phase 3 Terminated

63 enrolled 22 charts

Breast

Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

175 enrolled

Breast

Breast Neoplasms

NCT02927249 2023-04-05

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Phase 3 Terminated

3,021 enrolled 9 charts

Breast

Node Positive HER2 Negative Breast Cancer

NCT02332928 2023-03-30

Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy

Phase 3 Terminated

80 enrolled 15 charts

Breast

Breast Cancer - Female

NCT00543127 2023-03-10

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Phase 3 Terminated

870 enrolled 17 charts

Breast

Breast Neoplasms

NCT01905592 2022-11-15

BRAVO

Phase 3 Terminated

216 enrolled 19 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02340221 2022-07-12

SANDPIPER

Phase 3 Terminated

631 enrolled 49 charts

Breast

Breast Neoplasms

NCT01067144 2022-05-05

Stanford Accelerated Recovery Trial (START)

Phase 3 Terminated

422 enrolled 12 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Pain

NCT01608451 2022-05-02

Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer

Phase 3 Terminated

800 enrolled

Breast

Locally Advanced Breast Cancer and Large Operable Breast Cancer

NCT01077154 2021-09-28

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Phase 3 Terminated

4,509 enrolled 25 charts

Breast

Breast Neoplasms

NCT00508274 2021-09-21

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Phase 3 Terminated

52 enrolled 12 charts

Breast

Breast Neoplasms

NCT03326674 2021-07-30

CONTESSA

Phase 3 Terminated

685 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03905343 2021-06-16

Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC

Phase 3 Terminated

25 enrolled

Breast

Breast Neoplasms

NCT00296010 2021-02-23

CASA

Phase 3 Terminated

77 enrolled

Breast

Breast Neoplasms

NCT02730091 2021-02-01

VICTORIANE

Phase 3 Terminated

98 enrolled

Breast

Breast Neoplasms

NCT02137837 2021-01-28

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

Phase 3 Terminated

37 enrolled 16 charts

Breast

Breast Neoplasms

NCT03055312 2021-01-28

SYSUCC-007

Phase 3 Terminated

36 enrolled

Breast

Triple Negative Breast Neoplasms

NCT00625898 2020-09-10

BETH

Phase 3 Terminated

3,509 enrolled

Breast

Breast Neoplasms

NCT03050398 2020-05-28

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Phase 3 Terminated

8 enrolled 4 charts

BreastEndocrine

Breast Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT02532400 2020-03-11

COMPETE

Phase 3 Terminated

21 enrolled

Breast

Breast Neoplasms

NCT02054338 2019-08-28

VICTORIA

Phase 3 Terminated

1,004 enrolled 11 charts

Breast

Advanced Breast Cancer

NCT00908531 2019-04-29

REAL

Phase 3 Terminated

123 enrolled

Breast

Breast Neoplasms

NCT00130494 2019-04-16

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Phase 3 Terminated

97 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01633060 2019-01-30

BELLE-3

Phase 3 Terminated

432 enrolled 20 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT00206440 2018-12-06

NEXIUM

Phase 3 Terminated

43 enrolled 5 charts

Breast

Breast Neoplasms, Nausea, Vomiting

Clinical Trials

EPIK-B3

TSARINE

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

AXIL95

CLODIS

AMEERA-6

AMEERA-5

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

KATE3

eMonarcHER

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

IMpassion030

GLORY

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer

VERU-024

ARTEST

FORTRESS

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

PRAVAPREV-01

Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)

A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

BRAVO

SANDPIPER

Stanford Accelerated Recovery Trial (START)

Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

CONTESSA

Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC

CASA

VICTORIANE

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

SYSUCC-007

BETH

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

COMPETE

VICTORIA

REAL

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

BELLE-3

NEXIUM